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Abstract
The Microarray Gene Expression Data (MGED) society was formed with an initial
focus on experiments involving microarray technology. Despite the diversity of
applications, there are common concepts used and a common need to capture
experimental information in a standardized manner. In building the MGED ontology,
it was recognized that it would be impractical to cover all the different types of
experiments on all the different types of organisms by listing and deﬁning all the
types of organisms and their properties. Our solution was to create a framework for
describing microarray experiments with an initial focus on the biological sample and
its manipulation. For concepts that are common for many species, we could provide a
manageable listing of controlled terms. For concepts that are species-speciﬁc or whose
values cannot be readily listed, we created an ‘OntologyEntry’ concept that referenced
an external resource. The MGED ontology is a work in progress that needs additional
instances and particularly needs constraints to be added. The ontology currently
covers the experimental sample and design, and we have begun capturing aspects of
the microarrays themselves as well. The primary application of the ontology will be
to develop forms for entering information into databases, and consequently allowing
queries, taking advantage of the structure provided by the ontology. The application
of an ontology of experimental conditions extends beyond microarray experiments
and, as the scope of MGED includes other aspects of functional genomics, so too will
the MGED ontology. Copyright  2003 John Wiley & Sons, Ltd.
Keywords: microarray; ontology; MGED
Introduction
Microarray technology is a highly parallel method
to monitor the presence and/or abundance of bio-
logical molecules through hybridization to spe-
ciﬁc probes arrayed on a solid support, such as
a glass slide. The original and most widely used
application is for monitoring RNA abundance [17],
which has been applied in a wide variety of organ-
isms for a wide variety of purposes. In a typical
microarray study, biological materials (biomateri-
als) are collected and perhaps treated in some fash-
ion, RNA is extracted from these biomaterials, the
RNA is copied into complementary DNA (cDNA)
and labelled with ﬂuorescent dyes or radioactivity
for detection, the labelled cDNA is hybridized
to an array, an image of the array is generated,
and image intensities corresponding to the labelled
cDNA are quantiﬁed. Much of the attention on
microarray experiments has been focused on the
analysis of these quantiﬁed intensities that rep-
resent gene expression. Proper interpretation of
microarray experiments also requires an accurate,
unambiguous description of all the steps leading to
the generation of the quantiﬁed intensities. Descrip-
tions of the biology and design of the experiment
are as important as descriptions of the microarray
design and usage. Many of these descriptions, such
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Figure 1. Instances from the MGED ontology (part of which is shown) are used in forms used by the ArrayExpress
and RAD databases for data annotation and submission. New user deﬁned instances gleaned from submissions feed back
into the ontology after curation. Use of the ontology ensures that the databases are able to exchange meaningful data in
MAGE-ML format
as the details of protocols, are sufﬁciently captured
in text. However, it is necessary to query on some
descriptions (e.g. what organism was studied, what
was its age, and what pathology was associated
with it?) in order to ﬁnd experiments of interest
and group them appropriately. In order to query
these types of descriptions, it is necessary to pro-
vide them in a form that computer programs can
process and tell which are the same and which are
different. Describing the relevant aspects of bio-
logical materials used in microarray experiments
can be quite complex, and thus it is also impor-
tant to be able to specify the relationships between
these descriptions. For these reasons, an ontology
for microarray experiments is needed.
Ontologies have come to mean different things
to different people. We use the commonly cited
usage of Gruber [7]. That is, the concepts used
in our ontology are deﬁned and the relationships
between the concepts are speciﬁed. The ontology
is being built as part of a coordinated effort by
members of the microarray community through
the Microarray Gene Expression Data (MGED)
Society. MGED [12] has generated a set of guide-
lines for supplying the minimal information about
am icroarray experiment (MIAME, [3]). These
guidelines have provided the foundation for con-
cepts to be included in the ontology. A foundation
for the relationships between the concepts was pro-
vided by the MAGE effort [19], developed jointly
by MGED, Rosetta, and others. MAGE (microarray
gene expression) is an object model that has been
formally accepted as a standard by the Object Man-
agement Group (OMG, [15]) and implemented as
a form of XML (MAGE-ML).
The purpose of the MGED ontology is to
provide, either directly or indirectly, the terms
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needed to follow the MIAME guidelines and refer-
enced by MAGE. For example, MIAME asks that
the organism part used is supplied (when relevant),
and MAGE speciﬁes how biomaterial characteris-
tics such as organism part are encoded in a MAGE-
ML document. The terms for organism part are
not provided by either MIAME or MAGE, neither
are terms for describing the age of the sample, the
experimental design or the types of protocols used.
An experimental ontology
The MGED ontology is an ontology of exper-
iments, speciﬁcally microarray experiments, but
potentially extensible to other types of functional
genomics experiments. Although the major com-
ponent of the ontology involves biological descrip-
tions, it is not an ontology of molecular, cellular or
organismal biology. Rather, it is an ontology that
includes concepts of biological features relevant to
the interpretation and analysis of an experiment.
This distinction is critical for both establishing the
scope of the ontology and providing direction in its
construction.
Descriptions of biomaterials and their treat-
ments become very complex, even when limited
to aspects relevant to usage in a microarray exper-
iment. For example, a study consisting of mice
that have been given a compound in their drink-
ing water to test the effects on their livers requires
specifying what kind of mice, where they were
obtained, how they are housed, and how the com-
pound was delivered, in addition to the identity
and dose of the compound. Details of the exper-
imental design are needed as well, such as which
data sets came from which mice, and whether liv-
ers were pooled or split. These are all needed to
interpret the data obtained, as well as to reproduce
the experiment.
Experimental descriptions can be thought of as
falling into three categories: the types of informa-
tion (classes) that need to be captured, their prop-
erties (attributes) and the actual values (instances)
used. In our hypothetical study, we need to have
categories or classes for ‘organism’ to indicate that
mice were used, for ‘compound’ to indicate which
substance (or chemical) was used, and for ‘treat-
ment’ to indicate how the compound was admin-
istered to the mice. We also need classes for the
age, sex, strain and other characteristics that may
contribute to, or inﬂuence, the effects of the treat-
ment. Furthermore, we need classes for the experi-
mental, or study, design and what were the factors
of interest (e.g. the compound). Finally, as this is
a microarray experiment, we need classes for the
different types of protocols, arrays, hardware and
software that were used. As our goal is to facilitate
queries, we do not need to capture everything about
a microarray experiment, but we do need to provide
a way to unambiguously and consistently describe
relevant points, such as what kind of array platform
was used and whether protocols of a particular type
are provided.
The classes needed for a microarray experiment
ontology can be further broken down into two
categories. Some classes, such as those referring
to parts of the microarray experiment and cer-
tain features common to many experiments, can
be well described in terms of properties, values
and subclasses (and their properties and values).
For example, ‘treatment’ can be subclassed to dis-
tinguish compound-based treatments from treat-
ments involving behavioural stimuli. Compound-
based treatments can be given properties, such as
delivery method, measurement of the compound,
protocols and, of course, the compound itself. Even
though one can imagine many ways to deliver com-
pounds, it is reasonable to start to with a set of
common ones that can be added to. Measurement
requires the use of units; there are several kinds of
units (time, mass, etc.) and several values for these
units (hours, days, etc.), but these also can be easily
recorded to build the ontology. Thus, one cate-
gory of classes consists of those that can be built
in a straightforward manner and without requiring
extensive effort.
Another category of classes exists (e.g. com-
pound); however, that cannot be enumerated with-
out extensive effort; furthermore, many of these
classes have been the focus of efforts by other
groups to generate ontologies or various types of
controlled vocabularies. For this second category of
classes, the microarray community would be bet-
ter served by having pointers to such resources
rather than try to excerpt or recreate them. For
example, unlike units or delivery methods, one can-
not list the compounds that members of microar-
ray community are likely to use because of the
diversity of experiments that this community is
interested in. Instead, the MGED ontology can
refer to an external resource, such as ChemIDplus,
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available from the National Library of Medicine,
which includes 350000 chemical records that can
be searched by CAS Registry Number [4]. Another
example of a class covered by an existing ontol-
ogy is ‘organism’, for which the taxonomy avail-
able from the National Center for Biotechnol-
ogy Information [22] can be used. A third illus-
trative example is ‘disease’. For humans, multi-
ple choices are available, such as GALEN [6],
ICD-9 [9], SNOMED [18] and UMLS [21]. Hav-
ing multiple choices raises the issue of how one
chooses which is most appropriate to use and how
one maps between the same values or terms in the
different resources.
The approach taken in building the MGED ontol-
ogy is to specify both types of classes, providing
pointers to existing resources where appropriate,
and providing explicit values for those classes that
can be readily dealt with in this manner. Unlike
other efforts, such as UMLS, that try to bring
together different existing ontologies of the same
domain (e.g. disease), the MGED ontology does
not attempt to provide mappings between synony-
mous terms in different ontologies. This decision
is based again on the limited resources of MGED
and overwhelming diversity of domains for which
such mappings would be required. Instead, the
MGED ontology provides source information for
these terms, allowing queries to identify when the
terms came from different sources. These terms
are provided with the class of OntologyEntry. For
descriptions of the biological source (biosource) of
the material used in the microarray experiment,
a subclass BiosourceOntologyEntry was created.
Properties of OntologyEntry include an association
to a database entry that speciﬁes the resource for
terms for organism, disease, compound, etc.
The MGED ontology is being built with input
from the microarray community and reﬂects the
annotation needs of this community. The initial
emphasis, therefore, has been on biomaterials used,
and has included collecting the different annota-
tion resources that investigators use for inclusion in
OntologyEntry. The initial work has also included
the manipulations that the biomaterial undergoes
before collection (EnvironmentalHistory) and dur-
ing treatment (Treatment). Also included are the
manipulations for extracting RNA and generat-
ing labelled cDNAs (BiomaterialPreparation). The
focus turned next to the experimental or study
designs used and, most recently, an effort has begun
to provide annotation for different kinds of microar-
rays (platform, substrate, etc.) and the protocols
used to prepare and use them.
Status and implementation of the
ontology
The MGED ontology has been built using the
OilEd tool [2] because it provides an expressive
system covering both frame-based and descrip-
tion logics and it can import and export ﬁles
into commonly used formats, such as RDFS and
DAML + OIL. The current version of the ontol-
ogy is freely available, with supporting documen-
tation, from the MGED Ontology Working Group
website [13]. Currently, changes are made to the
MGED ontology only by the authors of this review;
however, a discussion list [14] is used to propose
changes and additions to the ontology.
MGED ontology version 1.6 contains 114 clas-
ses, 82 properties and 182 individuals. No axioms
(constraints) have been included yet, as we want
to ﬂesh out the ontology as much as possible ﬁrst.
The ontology covers the complete description of
the biomaterial used and the experimental or study
design. Coverage of the microarray platform and
protocols has begun and should be ﬁnished shortly.
The target consumers of the MGED ontology are
the investigators annotating experiments. Their pri-
mary interaction with the MGED ontology will be
through web-based forms to enter annotation into
a database. Such forms will use the MGED ontol-
ogy to provide the ﬁelds that need entering, the
dependencies between the ﬁelds, and the terms (in
drop-down menus or associated tables) to populate
those ﬁelds. It should be noted that the major-
ity of people using the MGED ontology are dif-
ferent from the software and database developers
using MAGE. The consequence is that develop-
ment of the MGED ontology will be annotation-
driven, whereas further development of MAGE is
software-driven. Nonetheless, as MAGE does pro-
vide some semantics as well as syntactic standards,
there is overlap with the MGED ontology and the
two groups have joint discussions on such issues.
The authors of this review have begun using
the MGED ontology in their own microarray gene
expression database efforts (see Figure 1). These
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include a public repository for all microarray exper-
iments (ArrayExpress, [1]) and integrated data sys-
tems that include microarray experiments for Plas-
modium falciparum (PlasmoDB; [10, 16]) and the
endocrine pancreas (EPConDB; [5]). PlasmoDB
and EPConDB are supported by the GUS sys-
tem [8], a relational database which now includes
RAD [20]. RAD has been updated and modiﬁed
to reﬂect the MGED standards. GUS also contains
a shared resources component (SRes) that holds
ontologies such as the MGED ontology. The RAD
component contains a table called OntologyEntry
that holds the components of the MGED ontology
actually used (or needed) for the microarray exper-
iments in RAD. The OntologyEntry table is used
to populate project-speciﬁc forms with this infor-
mation. For example, a PlasmoDB-speciﬁc form
has been built that only includes those parts of the
MGED ontology relevant to Plasmodium. The form
is based on a generic template that is also cus-
tomized for the EPConDB project. This approach
seeks to streamline the annotation process by pro-
viding terms for relevant ﬁelds and eliminating
irrelevant ﬁelds.
The ArrayExpress public repository for gene
expression data [1] uses the MAGE model and
aims to store MIAME-compliant data. In order
to help users annotate and submit their data,
a data submission tool, MIAMExpress [11], has
been developed. MIAMExpress is an array plat-
form — and experiment-type — independent tool
that is based on the MIAME questionnaire. It con-
sists of a series of web-based forms, and guides
the user through data submission and annotation of
the Experiment, the Protocols and the Array itself.
The most challenging part of this annotation is the
description of biological samples (Biomaterial) and
their treatments (BiomaterialManipulation); there-
fore, instances from the MGED ontology have been
used to populate the MIAMExpress forms which
the user completes in order to annotate the exper-
iment.
MIAMExpress is also a collection mechanism
for terms that are used to annotate experiments.
Users are offered the choice ‘other’ where no
appropriate term exists, and are asked to provide
a deﬁnition and a source for terms they provide.
A source could be an existing external ontology
(ExternalOntologyResource) or reference text. The
ArrayExpress curators evaluate these terms and
include them in MGED ontology where appropri-
ate. This allows synonyms to be removed before
inclusion in the MGED ontology and allows the
ontology to grow in a user-driven manner. In
future, versions of MIAMExpress species-speciﬁc
interfaces will be developed, and terms from exter-
nal ontologies will be included in addition to those
from the MGED ontology, thus providing a uni-
ﬁed interface for microarray annotation capable of
using many ontologies. MIAMExpress is an open
source project and is available for local installation
as an annotation tool.
Future of the ontology
The MGED ontology is now being developed to
directly support MAGE-OM and will continue to
grow as more microarray experiments are anno-
tated and the terms needed for this purpose are
shared. The MGED ontology will continue to
develop into new areas, in keeping with the mis-
sion of the MGED society. Microarrays are used for
purposes besides monitoring RNA abundance, and
as the needs grow for annotating experiments gen-
erated by those other microarray applications, so
will the impetus for including them in the MGED
ontology. Microarray studies are only one of many
approaches used in functional genomics that gen-
erate a large number of large datasets. Others, such
as mass spectrometry-based proteomics, will also
require standards and it is hoped that the experience
gained and tools built for microarrays can be lever-
aged for other functional genomics approaches. In
the case of the MGED ontology, the description of
experimental samples and design should be gener-
ally applicable.
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